Novartis Canada Receives Health Canada Approval For VANRAFIA For Proteinuria Reduction In Adults With Primary IgAN
NVS•Health Canada approval for VANRAFIA
-
Novartis Canada receives Health Canada approval for VANRAFIA for proteinuria reduction in adults with primary immunoglobulin A nephropathy.
-
July 13 (Reuters) - NOVARTIS CANADA:
